Product Benefits

• Dual-Action Therapy: Combines Flupentixol (a neuroleptic) and Melitracen (a bipolar thymoleptic) to provide simultaneous relief from both anxiety and depressive symptoms.

• Mood Elevation: Effectively treats apathy and lack of motivation, helping patients regain interest in their daily activities and social interactions.

• Psychosomatic Relief: Specifically indicated for physical symptoms caused by mental stress or emotional distress (psychosomatic affections).

• Targeted Symptom Management: Reliable for treating specialized conditions like "masked depression" (where physical pain hides underlying depression) and menopausal emotional instability.

• Activating Properties: Unlike some sedating antidepressants, U4 has activating properties at low doses, helping to improve energy levels without excessive sedation.

• Flexible Application: Beneficial for a wide range of patients, including those recovering from alcohol or drug addiction who suffer from dysphoria and mood swings.

• Low Side Effect Profile: When taken at the recommended dosage, side effects are rare, making it a well-tolerated option for long-term maintenance in appropriate patients.